Tencent Partners with Pfizer to Launch Smart Healthcare Innovation Ecosystem – Zhang Yu Highlights “Dual-Engine” Strategy for Healthcare Digitization
HANGZHOU, China, Oct. 9, 2024 /PRNewswire/ -- Tencent Health and Pfizer China have launched the "Pfizer Smart Healthcare Innovation Ecosystem" at the "Tides of Qiantang" Conference. This collaboration aims to drive innovation in smart healthcare solutions. Zhang Yu, Vice President of Tencent Health, outlined Tencent's "Dual-Engine Drive" strategy, which combines Tencent's core technologies—cloud computing, AI and big data—with the...
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking
TOKYO, Oct. 9, 2024 /PRNewswire/ -- Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") today announced its establishment as a joint venture company based on a master agreement signed on April 22, 2024 by Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO, Christophe Weber, "Takeda"), Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki...
AWAK Transforms into Vivance, Unveiling a New Brand Identity
SINGAPORE, Oct. 9, 2024 /PRNewswire/ -- AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived from 'viva' and 'advance', embodies vitality and progress - hallmarks of the company's commitment to revolutionizing kidney health. AWAK Technologies was founded with a groundbreaking idea: the...
Baird Medical to Participate in Roth’s 3rd Annual Healthcare Opportunities Conference
GUANGZHOU, China, Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced that the Company will participate in the following investor conference. Baird...
High tech specs and adapted World Cup pitch sensors awarded share of £1.5m as finalists in Longitude Prize on Dementia
AI glasses that help people living with dementia navigate their environment and a smartwatch that learns daily routines to assist in everyday tasks are among five groundbreaking technologies announced as finalists in The Longitude Prize on Dementia The Longitude Prize on Dementia is a £4.4m prize funded by Alzheimer's Society and Innovate UK and delivered by Challenge Works The...
Ubie, Inc. adds Google as an investor in its latest funding round
NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Ubie Inc. is pleased to announce that it has received investment from Google in its latest funding round. Ubie and Google investment Through this deal, the two companies agreed to help advance digital transformation of Japan's healthcare system using digital innovations including generative...
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative The two companies will co-establish a NewCo in Spain to serve as a strategic hub in Europe, accelerating global expansion of the initiative Localization of Seegene's syndromic real-time PCR product development and...
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it is providing financial guidance for the half year of its fiscal year of...
Korea’s SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, including those for pneumoniae and typhoid. The company will accelerate its future growth strategies by exploring and investing in promising global companies. SEONGNAM, South Korea...
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell...
PFL-241/STX-241 is a highly selective, and potentially best-in-class fourth generation epidermal growth factor receptor ("EGFR") inhibitor One of two EGFR programs being developed with Scorpion Therapeutics CASTRES, France and BOSTON, Oct. 8, 2024 /PRNewswire/ -- Pierre Fabre Laboratories, a global player in oncology, and Scorpion Therapeutics, Inc. ("Scorpion"), a pioneering clinical-stage oncology...
